California Cancer Reporting System Standards, Volume III

IF1138: Primary Site, Heme Morph, DateDX, Override

OWNER

SEER

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3  [NAACCR #523]

Date of Diagnosis [NAACCR #390]

Over-ride Site/Type [NAACCR #2030]

TABLE

N/A

MESSAGE

1. IF1138: If Date of Diagnosis is 2010 or later, Histologic Type ICD-O-3 = [value] and Primary Site is not = C770-C779, review required.

2. IF1138: If Date of Diagnosis is 2010 or later, Histologic Type ICD-O-3 = [value] and Primary Site not skin lymphoma, review required

3. IF1138: If Date of Diagnosis is 2010 or later, Histologic Type ICD-O-3 = [value] and Primary Site = [value], review required

4. IF1138: If Date of Diagnosis is 2010 or later, Histologic Type ICD-O-3 = [value] and Primary Site not skin or soft tissue lymphoma, review required

specification

This edit complements the edit ‘Primary Site, Morphology-Type,Beh ICDO3(SEER IF25)’ which is based on the ICD-O-3 SEER Site/Histology Validation List and requires review of unusual site/histology/behavior combinations. ‘Primary Site, Morphology-Type,Beh ICDO3(SEER IF25)’ does not check diagnosis year.  This edit checks diagnosis year and narrows the list of preferred site codes for some hematopoietic histologies for cases diagnosed 2010 and later.  Cases with primary sites that are not included in the preferred list must be reviewed. If upon review the site/type combination is found to be accurate and in conformance with coding rules, it may be left as coded and the Over-ride-Site/Type flag coded to 1.

This version of the edit includes the over-ride field 'Over-ride Site/Type' and should run at the central registry level.  The hospital registry version of this edit is 'Primary Site, Heme Morph, DateDX, Override (COC)' and includes the hospital level field 'Over-ride COC-Site/Type' instead of the central registry field 'Over-ride Site/Type.'

Sources:

- Hematopoietic and Lymphoid Neoplasm Database & Coding Manual(Appendix E)

- 2015 Implementation Guidelines and Recommendations, Appendix B, Table 3

This edit is skipped if any of the following conditions are true:

1. Primary Site is blank

2. Histologic Type ICD-O-3 is blank or not in range 9590-9992

3. Behavior Code ICD-O-3 is blank or not = 3

4. Date of Diagnosis is blank or invalid

5. Over-ride Site/Type = 1

If year of diagnosis is 2010 or later, the following Primary Site codes are the preferred codes for use with the listed Histologic Type ICD-O-3 codes. If other Primary Site codes are coded and, after review, determined to be correct, the Over-ride Site/Type should be set to '1'.

9650, 9651, 9652, 9653, 9655, 9659, 9663,9688

    C770-C779

9597, 9700, 9701, 9709, 9718, 9725

    C440-C449, C510-C512, C518-C519, C600-C602, C608-C609, C632

9708, 9726

    C440-C449, C490-C499, C510-C512, C518-C519, C600-C602, C608-C609, C632

9719

    C050-C059, C110-C119 C300-C301, C310-C319

9751

    C340-C349, C400-C419, C421, C440-C449, C490-C499, C770-C779

historical changes